When did PROQR THERAPEUTICS NV (PRQR) report earnings last quarter?
PROQR THERAPEUTICS NV (PRQR) last reported earnings on 3/12/2026.
PROQR THERAPEUTICS NV (PRQR) Earnings History & Surprises
NASDAQ:PRQR • NL0010872495
Current stock price
1.615 USD
+0.1 (+6.95%)
Last:
PRQR Earnings overview
Past quarterly earnings results for PROQR THERAPEUTICS NV (PRQR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -€0.12
- Revenue Estimate
- 4.502M
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -€0.08
- EPS Surprise
- 18.82%
- Revenue Surprise
- 20.70%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.08 | -0.10 | 18.82% | 10.25% | 4.688M | 3.884M | 20.70% | 8.85% |
| Q3 2025 | -0.10 | -0.11 | 4.77% | - | 2.882M | 4.45M | -35.24% | -25.01% |
| Q2 2025 | -0.12 | -0.08 | -43.58% | -300.00% | 3.817M | 4.541M | -15.94% | -39.46% |
| Q1 2025 | -0.10 | -0.09 | -6.02% | -11.11% | 4.519M | 4.616M | -2.10% | 1.55% |
| Q4 2024 | -0.09 | -0.09 | 0.34% | -33.70% | 4.307M | 6.011M | -28.35% | -30.70% |
| Q3 2024 | -0.10 | -0.11 | 7.09% | -42.86% | 3.843M | 11.296M | -65.98% | 180.51% |
| Q2 2024 | -0.03 | -0.13 | 76.42% | 70.00% | 6.305M | 11.685M | -46.04% | 407.65% |
| Q1 2024 | -0.09 | -0.11 | 19.45% | 18.18% | 4.45M | 3.2M | 39.06% | 579.39% |
| Q4 2023 | -0.07 | 0.01 | -732.51% | 56.25% | 6.215M | 15.027M | -58.64% | 374.43% |
| Q3 2023 | -0.07 | -0.09 | 19.37% | 79.41% | 1.37M | 3.383M | -59.50% | 53.93% |
| Q2 2023 | -0.10 | -0.11 | 11.76% | 52.38% | 1.242M | 1.242M | - | 20.58% |
| Q1 2023 | -0.11 | -0.12 | 8.34% | 45.00% | 655K | 1.341M | -51.16% | -46.75% |
| Q4 2022 | -0.16 | -0.18 | 12.13% | 38.46% | 1.31M | 975.446K | 34.30% | 197.73% |
| Q3 2022 | -0.34 | -0.21 | -58.31% | -54.55% | 890K | 855.77K | 4.00% | -23.28% |
| Q2 2022 | -0.21 | -0.22 | 4.64% | 12.50% | 1.03M | 731.728K | 40.76% | 58.46% |
| Q1 2022 | -0.20 | -0.24 | 16.75% | 20.00% | 1.23M | 553.615K | 122.18% | 778.57% |
| Q4 2021 | -0.26 | -0.19 | -37.23% | - | 440K | 402.084K | 9.43% | 69.23% |
| Q3 2021 | -0.22 | -0.21 | -5.20% | 15.38% | 1.16M | 236.181K | 391.15% | 364.00% |
| Q2 2021 | -0.24 | -0.24 | 0.80% | -200.00% | 650K | 195.381K | 232.68% | -92.50% |
| Q1 2021 | -0.25 | -0.25 | 1.84% | 21.88% | 140K | 463.304K | -69.78% | -46.15% |
| Q4 2020 | -0.26 | -0.26 | -1.57% | - | 260K | 191.944K | 35.46% | - |
| Q3 2020 | -0.26 | -0.31 | 15.21% | - | 250K | 141.413K | 76.79% | - |
| Q2 2020 | -0.08 | -0.33 | 76.06% | - | 8.67M | 426.044K | 1,935.00% | - |
| Q1 2020 | -0.32 | -0.35 | 8.27% | - | 260K | 426.044K | -38.97% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-6.50%
Max EPS beat (4)
18.82%
Min EPS beat (4)
-43.58%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-8.15%
Max Revenue beat (4)
20.70%
Min Revenue beat (4)
-35.24%
Analysis
In the last 4 quarters, PRQR has beaten EPS estimates in 2 out of 4 releases
PRQR has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, PRQR reported -6.5% below the EPS estimates on average.
In the last 4 quarters, PRQR reported -8.1% below the revenue estimates on average.
Related analysis
PROQR THERAPEUTICS NV / PRQR Earnings FAQ
Can you provide information on whether PROQR THERAPEUTICS NV beat earnings estimates in the last quarter?
PROQR THERAPEUTICS NV (PRQR) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does PRQR stock beat earnings estimates?
In the last 4 quarters, PROQR THERAPEUTICS NV (PRQR) has beaten EPS estimates in 2 out of 4 releases.